Status:
COMPLETED
Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome
Lead Sponsor:
Regional Hospital Holstebro
Conditions:
Nephrotic Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
We want to test the hypothesises that patients with nephrotic syndrome have a higher excretion of AQP2 in the urine,that they have a higher concentration of AVP,and a lower C-H2O.Everything will norma...
Eligibility Criteria
Inclusion
- adult patients with nephrotic syndrome in the years 1995 until now; both male and female; the kidney disease must be based upon a kidney biopsy ; age \> 18 years -
Exclusion
- severe diseases in the heart, lungs or liver; diabetes mellitus; other not well-treated diseases in endocrine organs; cancer unwillingness to participate
- \-
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00286910
Start Date
May 1 2005
Last Update
March 18 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Holstebro Hospital
Holstebro, Denmark, 7500